Introduction: Hyponatremia has already been described in sever acute respiratory syndrome (SARS) which was associated with poor outcome.
This is also seen in sars-cov-2 for the most part with moderate to severe infection. Thus, hyponatremia can be taken as a prognostic factor. Severe
hyponatremia has long been recognized as a direct cause of death or permanent neurological alterations. Patients with Coronavirus disease 2019
(COVID-19), caused by SARS-COV2 infection, can develop a potentially fatal rapid-onset pneumonia.
Aim:To describe the impact of hyponatremia on COVID-19 patient outcome.
Material and methods:It is a retrospective study on the patient admitted in Peerless Hospital and diagnosed COVID 19 positive, conrmed by RTPCR or Gene – X pert. Data of the serum sodium concentrations of patients with COVID19 infection after admission and analysed the relationship
between the serum sodium and severity of the illness and its outcome. 320 participants were taken.
Result: In our study, 131(40.9%) COVID-19 patients were in Hyponatremic and 189(59.1%) COVID-19 patients were in Normonatremic group.
High Systolic blood pressure, High Diastolic blood pressure, low SPO2 and high Respiratory rate was observed in Hyponatremic COVID-19
patients which were statistically signicant. 272 (85.0%) patients were Alive and 48 (15.0%) patients were Death.
Conclusion: Our study showed an independent relationship between 131 Hyponatremic COVID-19 patients at admission and transfer to ICU, use
of mechanic ventilation or death. Our results support the test sodium in hospitalized COVID-19 patients as another bedside screening tool for early
identication of patients at high risk of poor outcome.
Immediate postoperative diastolic blood pressure as a prognostic factor in living donor kidney transplantation
